JOSE CARLOS
ARMARIO HITA
Profesor Titular de Universidad
José-Juan
Pereyra-Rodríguez
Publicaciones en las que colabora con José-Juan Pereyra-Rodríguez (20)
2024
-
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
Journal of the European Academy of Dermatology and Venereology
2023
-
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
Acta Dermato-Venereologica, Vol. 103
-
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient's Perspective: A Systematic Review
Dermatitis
-
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Journal of Investigational Allergology and Clinical Immunology
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
-
Upadacitinib for moderate to severe atopic dermatitis
Immunotherapy, Vol. 15, Núm. 11, pp. 799-808
2022
-
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)
Life
-
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
Life, Vol. 12, Núm. 8
-
Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort-Real Life: Fifty-Two-Week Follow-up Results
Dermatitis : contact, atopic, occupational, drug, Vol. 33, Núm. 6, pp. S124-S127
-
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
International journal of environmental research and public health, Vol. 19, Núm. 17
2021
-
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
Anais Brasileiros de Dermatologia, Vol. 96, Núm. 6, pp. 787-790
-
Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study
British Journal of Dermatology
-
Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis
Life, Vol. 11, Núm. 9
2020
-
A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228
-
Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain
Dermatologic Therapy, Vol. 33, Núm. 6
-
The Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 699-700
2019
-
Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study
Journal of the European Academy of Dermatology and Venereology
-
Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series
Dermatologic Therapy, Vol. 32, Núm. 4
-
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
British Journal of Dermatology